Caplin Point Laboratories Ltd. Financials: Quarterly Results
Revenue
528.19
Cr.
PAT
145.20
Cr.
EBITDA
176.76
Cr.
Caplin Point Laboratories Ltd. Q4FY25 Financial Metrics
| Indicator | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 502.45 | 492.96 | 483.10 | 458.96 | 453.22 |
| Total Income From Operations (Cr.) | 502.45 | 492.96 | 483.10 | 458.96 | 453.22 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 176.76 | 177.45 | 168.77 | 154.41 | 146.12 |
| P/L Before Exceptional Items & Tax (Cr.) | 176.59 | 177.27 | 168.56 | 154.36 | 145.97 |
| P/L After Tax from Ordinary Activities (Cr.) | 145.20 | 140.08 | 130.91 | 124.90 | 121.17 |
| Net Profit/Loss For the Period (Cr.) | 145.20 | 140.08 | 130.91 | 124.90 | 121.17 |
| Basic EPS | 18.75 | 18.28 | 17.22 | 16.32 | 16.01 |
FAQs
Caplin Point Laboratories Ltd. announced its quarterly results for Q4 FY2025 on May 15, 2025.
In Q4 FY2025, Caplin Point Laboratories Ltd. are as follows:
Revenue: ₹528.19 crore
Net Profit: ₹145.20 crore.
For Q4 FY2025, Caplin Point Laboratories Ltd. posted ₹528.19 crore in revenue and ₹145.20 crore in net profit.
Past quarterly results for Caplin Point Laboratories Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.